Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis

This study was carried out to evaluate the vaccination effect of a virus-like particle (VLP) including the surface antigen 1 (SAG1) of Toxoplasma gondii as a potential vaccine for toxoplasmosis. The SAG1 virus-like particles (SAG1-VLPs) were expressed by Sf9 cells, and their expression was confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Won Hyung, Park, Ji Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235809/
https://www.ncbi.nlm.nih.gov/pubmed/32325746
http://dx.doi.org/10.3390/biomedicines8040091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235809/
https://www.ncbi.nlm.nih.gov/pubmed/32325746
http://dx.doi.org/10.3390/biomedicines8040091

Ejemplares similares